Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human PRMT7 aa 550-650. The exact sequence is proprietary.Database link: Q9NVM4
Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Specifically mediates the symmetric dimethylation of histone H4 Arg-3 to form H4R3me2s. Plays a role in gene imprinting by being recruited by CTCFL at the H19 imprinted control region (ICR) and methylating histone H4 to form H4R3me2s, possibly leading to recruit DNA methyltransferases at these sites. May also play a role in embryonic stem cell (ESC) pluripotency. Also able to mediate the arginine methylation of histone H2A and myelin basic protein (MBP) in vitro; the relevance of such results is however unclear in vivo.
Citations
Publication ()
Have you cited DCABH-7192 in a publication? Let us know and earn a reward for your research.
Q: May I know the buffer formulation for Anti-PRMT7 monoclonal antibody, clone FQS24506?
A: Yes, the buffer formulation for Anti-PRMT7 monoclonal antibody, clone FQS24506 is supplied in Preservative: 0.01% Sodium azide; Constituents: 59% PBS, 40% Glycerol, 0.05% BSA.
Customer Reviews
My Review for Anti-PRMT7 monoclonal antibody, clone FQS24506
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.